Review Article
Molecular Drivers of Potential Immunotherapy Failure in Adrenocortical Carcinoma
Table 1
Clinical studies investigating immunotherapy in ACC.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ORR: overall response rate; OS: overall survival; PFS: progression-free survival. |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ORR: overall response rate; OS: overall survival; PFS: progression-free survival. |